Display options
Cite
Dragoteanu M, Balea IA, Piglesan CD. Nuclear medicine dynamic investigations in the diagnosis of Budd-Chiari syndrome. World J Hepatol. 2014;6(4):251-62doi: 10.4254/wjh.v6.i4.251.
Dragoteanu, M., Balea, I. A., & Piglesan, C. D. (2014). Nuclear medicine dynamic investigations in the diagnosis of Budd-Chiari syndrome. World journal of hepatology, 6(4), 251-62. https://doi.org/10.4254/wjh.v6.i4.251
Dragoteanu, Mircea, et al. "Nuclear medicine dynamic investigations in the diagnosis of Budd-Chiari syndrome." World journal of hepatology vol. 6,4 (2014): 251-62. doi: https://doi.org/10.4254/wjh.v6.i4.251
Dragoteanu M, Balea IA, Piglesan CD. Nuclear medicine dynamic investigations in the diagnosis of Budd-Chiari syndrome. World J Hepatol. 2014 Apr 27;6(4):251-62. doi: 10.4254/wjh.v6.i4.251. PMID: 24799994; PMCID: PMC4009481.
Copy Download .nbib Format: NLM
Share it on

World J Hepatol. 2014 Apr 27;6(4):251-62. doi: 10.4254/wjh.v6.i4.251.

Nuclear medicine dynamic investigations in the diagnosis of Budd-Chiari syndrome.

World journal of hepatology

Mircea Dragoteanu, Ioan-Adrian Balea, Cecilia-Diana Piglesan

Affiliations

  1. Mircea Dragoteanu, Ioan-Adrian Balea, Cecilia-Diana Piglesan, Department of Nuclear Medicine, Regional Institute for Gastroenterology and Hepatology, Prof. Dr. Octavian Fodor, 400162 Cluj-Napoca, Romania.

PMID: 24799994 PMCID: PMC4009481 DOI: 10.4254/wjh.v6.i4.251

Abstract

AIM: To investigate the hepatic hemodynamics in the Budd-Chiari syndrome (BCS) using per-rectal portal scintigraphy (PRPS) and liver angioscintigraphy (LAS).

METHODS: Fourteen consecutive patients with BCS were evaluated by PRPS between 2003 and 2012. Ten of them underwent LAS and liver scan (LS) with Tc-99m colloid. Eleven patients had clinical manifestations and three were asymptomatic, incidentally diagnosed at PRPS. The control group included 15 healthy subjects. We used new parameters at PRPS, the liver transit time of portal inflow and the blood circulation time between the right heart and liver. PRPS offered information on the hepatic areas missing venous outflow or portal inflow, length and extent of the lesions, open portosystemic shunts (PSS), involvement of the caudate lobe (CL) as an intrahepatic shunt and flow reversal in the splenic vein. LAS was useful in the differential diagnosis between the BCS and portal obstructions, highlighting the hepatic artery buffer response and reversed portal flow. LS offered complementary data, especially on the CL.

RESULTS: We described three hemodynamic categories of the BCS with several subtypes and stages, based on the finding that perfusion changes depend on the initial number and succession in time of the hepatic veins (HVs) obstructions. Obstruction of one hepatic vein (HV) did not cause opening of PSS. The BCS debuted by common obstruction of two HVs had different hemodynamic aspects in acute and chronic stages after subsequent obstruction of the third HV. In chronic stages, obstruction of two HVs resulted in opening of PSS. The BCS, determined by thrombosis of the terminal part of the inferior vena cava, presented in the acute stage with open PSS with low speed flow. At least several weeks are required in the obstructions of two or three HVs for the spontaneous opening of dynamically efficient PSS. The CL seems to have only a transient important role of intrahepatic shunt in several types of the BCS.

CONCLUSION: Dynamic nuclear medicine investigations assess the extent and length of hepatic venous obstructions, open collaterals, areas without portal inflow, hemodynamic function of the CL and reverse venous flow.

Keywords: Budd-Chiari syndrome; Caudate lobe; Hepatic veins; Liver angioscintigraphy; Per-rectal portal scintigraphy

References

  1. Can J Gastroenterol. 2011 Jun;25(6):302-3 - PubMed
  2. J Gastroenterol. 1998 Aug;33(4):517-22 - PubMed
  3. Br J Surg. 1985 Feb;72(2):128-30 - PubMed
  4. Gut. 1986 Sep;27(9):1101-5 - PubMed
  5. World J Gastroenterol. 2008 Jun 28;14(24):3841-8 - PubMed
  6. Ann Radiol (Paris). 1991;34(6-7):362-8 - PubMed
  7. Am J Gastroenterol. 1995 Mar;90(3):460-5 - PubMed
  8. Mayo Clin Proc. 1990 Jan;65(1):51-5 - PubMed
  9. Ann Surg. 2000 Sep;232(3):340-52 - PubMed
  10. Abdom Imaging. 2011 Aug;36(4):399-406 - PubMed
  11. AJR Am J Roentgenol. 2003 Dec;181(6):1641-5 - PubMed
  12. Indian J Gastroenterol. 2009 Jan-Feb;28(1):17-23 - PubMed
  13. Abdom Imaging. 1994 Jul-Aug;19(4):325-9 - PubMed
  14. Hepatobiliary Pancreat Dis Int. 2012 Aug 15;11(4):429-33 - PubMed
  15. Rom J Gastroenterol. 2004 Dec;13(4):351-7 - PubMed
  16. AJR Am J Roentgenol. 1992 Jul;159(1):113-6 - PubMed
  17. Ann Intern Med. 2009 Aug 4;151(3):167-75 - PubMed
  18. Mediterr J Hematol Infect Dis. 2011;3(1):e2011063 - PubMed
  19. J Hepatol. 2003 Mar;38(3):364-71 - PubMed
  20. Abdom Imaging. 2003 Sep-Oct;28(5):668-74 - PubMed
  21. Rom J Gastroenterol. 2004 Mar;13(1):55-63 - PubMed
  22. Radiology. 1987 Nov;165(2):409-13 - PubMed
  23. J Hepatol. 2001 Sep;35(3):338-43 - PubMed
  24. J Hepatol. 2008 Oct;49(4):572-80 - PubMed
  25. Gastroenterology. 1994 Apr;106(4):1042-7 - PubMed
  26. Semin Ultrasound CT MR. 1995 Feb;16(1):34-48 - PubMed
  27. Gut. 1987 Mar;28(3):242-7 - PubMed
  28. J Hepatol. 2009 Jan;50(1):195-203 - PubMed
  29. Radiology. 1995 Apr;195(1):117-21 - PubMed
  30. World J Radiol. 2011 Jul 28;3(7):169-77 - PubMed
  31. Surg Oncol Clin N Am. 2002 Oct;11(4):835-48 - PubMed
  32. Semin Liver Dis. 2008 Aug;28(3):259-69 - PubMed
  33. World J Surg. 2012 Jan;36(1):120-4 - PubMed
  34. J Gastroenterol Hepatol. 1999 Sep;14(9):904-7 - PubMed
  35. Surg Radiol Anat. 2008 May;30(3):201-7 - PubMed

Publication Types